openPR Logo
Press release

Propranolol Drug Market Forecast Report Offers Actionable Insights 2016-2026

01-18-2018 06:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Propranolol Drug Market Forecast Report Offers Actionable

Propranolol is a beta adrenergic receptor-blocking type medication used in the treatment or prevention of high blood pressure, post-traumatic stress disorder, irregular heartbeats, tremors, angina pectoris, migraine and anxiety. According to study published in American Heart Association, Inc., hypertension is the leading risk factor for disability and death worldwide. In 2010, Asia and Pacific region had highest burden of hypertension with 439 Mn people suffering from hypertension. As per WHO, propranolol is considered as one of the most essential pharmaceutical drug required in a basic health system. The drug is non selective beta blocker and also able to cross via blood –brain barrier. It inhibit the actions of neurotransmitter and enhances memory consolidation. This advantage of propranolol made it useful for brain disorder too, which created a positive impact of propranolol drug in both heart and brain disorder. Propranolol drug is investigated as potential treatment for post-traumatic stress disorder. Propranolol was first marketed in 1965 under the brand name Inderal by ICI Pharmaceutical which is now known as AstraZeneca.

Propranolol Drug Market: Drivers and Restraints

The global market for propranolol drug market is expected to be driven by rise in incidence of hypertension, and rapidly changing lifestyles in developing countries. Moreover, advancement in pharmaceutical market and funding initiatives in R&D sector are some other key factors that expected to propel the growth of propranolol drug market in the forecast period. As propranolol is a non-selective beta- blocker drug, it shows similar results on lungs, heart and other areas of body, which contributes to the adverse effects like allergic reaction, breathing problem, sudden weight gain, changes in blood sugar etc. Alternative option for propranolol drug and side effects related to drug may restrain the growth of this market.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2028

Propranolol Drug Market: Segmentation

The global propranolol drug market is classified on the basis of route of administration, disease indication and end user.

Based on of route of administration, the global propranolol drug market is segmented into the following:

Oral administration

Solid

Liquid

IV administration

Based on disease indication, the global propranolol drug market is segmented into the following:

Hypertension

Angina

Migraine

Tremors

Based on end user, the global propranolol drug market is segmented into the following:

Hospitals

Clinics

Home care settings

Ambulatory Surgical Centers

Propranolol Drug Market: Overview

North America and Europe lead the propranolol drug market due to increase in sedentary lifestyles and increasing aging population, which ultimately increases the rate of hypertension and angina related cases. Under route of administration segment, oral route shows high market growth in propranolol drug market as tablet form is more prescribed by doctors for long term positive effects. Tablets and extended-release capsules come under this segment, which are more preferred and shows favorable patient outcomes. Based on disease indication segment, hypertension account for high shares as compared with other disease types in the propranolol drug market. Hypertension is lifelong disease that means, patient may require to take tablets every day for rest of the life.

Propranolol Drug Market: Regional Overview

Region wise, the global propranolol drug market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for propranolol drug market. As per the study published by Center for Disease Control and Prevention (CDC) in 2014, nearly 70 Mn American population suffered from hypertension and expected to increase in coming years which will create growth opportunity for propranolol drug market. On other hand, Asia-Pacific is expected to grow at a fast pace over the forecast period owing to changing lifestyle and growing disease population. Moreover, variouspublic awareness programs initiated by medical organizations, to encourage people for regular checkups and explore available treatment options, will result in the strong growth opportunity of propranolol drug market in these regions.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-2028

Propranolol Drug Market: Key Players

Some of the key players in global propranolol drug market includes Glaxosmithkline, Mylan pharmaceuticals inc, Actavis elizabeth llc, Inwood laboratories inc sub forest laboratories inc, Roxane laboratories inc, Baxter healthcare corp, Bedford laboratories, Wyeth ayerst laboratories, Ipca laboratories ltd, Teva pharmaceuticals, Vintage pharmaceuticals, Northstar healthcare holdings ltd, Pliva inc, Interpharm inc, Ivax pharmaceuticals inc, Clonmel healthcare ltd.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Abhishek Bhudoliya
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: http://www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Propranolol Drug Market Forecast Report Offers Actionable Insights 2016-2026 here

News-ID: 905678 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Propranolol

Propranolol Market Analysis and Global Research Report 2021-2026
MarketInsightsReports recently published a research report called Propranolol Market. Primary and secondary research methods were used to construct this report. The Analysis was derived using history and predictions. The report includes an in-depth study of geographic regions, revenue forecasts, segmentation, and market share. The global Propranolol Market is expected to flourish in terms of volume and value over the forecast period. The report provides an understanding of the various drivers, threats, opportunities, and limitations of the
Propranolol Drug Market : Overall Growth, Major Industry Leaders & Future Insigh …
Propranolol is a beta adrenergic receptor-blocking type medication used in the treatment or prevention of high blood pressure, post-traumatic stress disorder, irregular heartbeats, tremors, angina pectoris, migraine and anxiety. According to study published in American Heart Association, Inc., hypertension is the leading risk factor for disability and death worldwide. In 2010, Asia and Pacific region had highest burden of hypertension with 439 Mn people suffering from hypertension. As per WHO,
Propranolol market development trends, competitive landscape and key players 201 …
The 'Global and Chinese Propranolol Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Propranolol Market with a focus on the Chinese market. The report provides key statistics on the market status of the Propranolol manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of
Propranolol Drug Market Global Industry Analysis, Trends and Forecast, 2016-2026
Propranolol is a beta adrenergic receptor-blocking type medication used in the treatment or prevention of high blood pressure, post-traumatic stress disorder, irregular heartbeats, tremors, angina pectoris, migraine and anxiety. According to study published in American Heart Association, Inc., hypertension is the leading risk factor for disability and death worldwide. In 2010, Asia and Pacific region had highest burden of hypertension with 439 Mn people suffering from hypertension. As per WHO,
Market Size of Propranolol Drug Market, Forecast Report 2016-2026
Propranolol is a beta adrenergic receptor-blocking type medication used in the treatment or prevention of high blood pressure, post-traumatic stress disorder, irregular heartbeats, tremors, angina pectoris, migraine and anxiety. According to study published in American Heart Association, Inc., hypertension is the leading risk factor for disability and death worldwide. In 2010, Asia and Pacific region had highest burden of hypertension with 439 Mn people suffering from hypertension. As per WHO,
Propranolol Drug Market Globally Expected to Drive Growth through 2026
Propranolol is a beta adrenergic receptor-blocking type medication used in the treatment or prevention of high blood pressure, post-traumatic stress disorder, irregular heartbeats, tremors, angina pectoris, migraine and anxiety. According to study published in American Heart Association, Inc., hypertension is the leading risk factor for disability and death worldwide. In 2010, Asia and Pacific region had highest burden of hypertension with 439 Mn people suffering from hypertension. As per WHO,